Adverum Biotechnologies

Home » Adverum Biotechnologies

Secondary

Adverum Biotechnologies

They are a clinical-stage gene therapy company targeting unmet medical needs in serious rare and ocular diseases

Symbol

ADVM

Last Closing Price
$7.10

Shares
7,100,000

Effective Date
February 8, 2018

Underwriters
Cowen, Piper Jaffray

To view the prospectus for Adverum Biotechnologies, or any offering listed on ClickIPO,
download the ClickIPO app...

or a prospectus can be requested from G. Price at
ClickIPO Securities, LLC 8601 N Scottsdale Rd, Suite 335, Scottsdale, AZ 85253